Evaxion Biotech Analyst Ratings
Evaxion Biotech Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/17/2022 | 397.74% | Oppenheimer | $16 → $11 | Maintains | Outperform |
| 07/18/2022 | 623.98% | Oppenheimer | → $16 | Assumes | → Outperform |
| 03/02/2021 | 714.48% | Oppenheimer | → $18 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 11/17/2022 | 397.74% | 奧本海默 | $16 → $11 | 維護 | 跑贏大盤 |
| 07/18/2022 | 623.98% | 奧本海默 | → $16 | 假設 | →跑贏大盤 |
| 03/02/2021 | 714.48% | 奧本海默 | → $18 | 開始承保 | →跑贏大盤 |
What is the target price for Evaxion Biotech (EVAX)?
Evaxion Biotech(EVAX)的目標價格是多少？
The latest price target for Evaxion Biotech (NASDAQ: EVAX) was reported by Oppenheimer on November 17, 2022. The analyst firm set a price target for $11.00 expecting EVAX to rise to within 12 months (a possible 397.74% upside). 2 analyst firms have reported ratings in the last year.
奧本海默於2022年11月17日報道了Evaxion Biotech(納斯達克：EVAX)的最新目標價。這家分析公司將目標價定為11美元，預計EVAX將在12個月內上漲至(可能上漲397.74%)。去年有兩家分析公司公佈了評級。
What is the most recent analyst rating for Evaxion Biotech (EVAX)?
Evaxion Biotech(EVAX)的最新分析師評級是多少？
The latest analyst rating for Evaxion Biotech (NASDAQ: EVAX) was provided by Oppenheimer, and Evaxion Biotech maintained their outperform rating.
奧本海默公司提供了對依華信生物科技公司(納斯達克代碼：EVAX)的最新分析師評級，依華信生物科技公司維持了其表現優於大盤的評級。
When is the next analyst rating going to be posted or updated for Evaxion Biotech (EVAX)?
Evaxion Biotech(EVAX)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Evaxion Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Evaxion Biotech was filed on November 17, 2022 so you should expect the next rating to be made available sometime around November 17, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閲公共財務報表，與Evaxion Biotech的高管和客户交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Evaxion Biotech的上一次評級是在2022年11月17日提交的，所以你應該預計下一次評級將在2023年11月17日左右的某個時候公佈。
Is the Analyst Rating Evaxion Biotech (EVAX) correct?
分析師對Evaxion Biotech(EVAX)的評級正確嗎？
While ratings are subjective and will change, the latest Evaxion Biotech (EVAX) rating was a maintained with a price target of $16.00 to $11.00. The current price Evaxion Biotech (EVAX) is trading at is $2.21, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Evaxion Biotech(EVAX)評級維持不變，目標價在16.00美元至11.00美元之間。Evaxion Biotech(EVAX)目前的股價為2.21美元，超出了分析師的預測區間。